1. Introduction {#sec1}
===============

γ-Cyclodextrin metal--organic frameworks (γCDMOF) are porous crystalline materials represented by the formula K~2~(C~48~H~80~O~40~)(OH)~2~, composed of γCD and K^+^ and OH^--^ ions giving rise to electrostatic interactions. The crystal cell parameters are *a* = *b* = *c* = 31.006 Å and α = β = γ = 90.00° ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).^[@ref1]^ The regular architecture of γCDMOF made of large pores and channels attracted the interest of researchers in an attempt to optimize their synthesis^[@ref1]^ and develop applications in the fields of gas storage^[@ref2]^ or drug delivery.^[@ref3]^

![Crystal structure of γCDMOF. Gray, carbon; red, oxygen; purple, kalium. Hydrogen atoms were deleted.](ao9b01634_0004){#fig1}

Drug loading and release characteristics are the most evaluated parameters for the development of novel drug delivery carriers. However, no attention has been paid yet to loading/release mechanisms of γCDMOF, leaving it scientifically untouched topic. An impregnation method is commonly used for drug loading in γCDMOF, but it requires long periods of time (up to 18 h^[@ref3]^). The scientific reasons for such long impregnation times despite the highly porous interconnected structure of γCDMOF are still unclear. Therefore, there is a high interest to explain the drug loading mechanism, which would speed up this very particular research field. Molecular modeling is a useful tool to provide insights into the molecular level on the release mechanism of this new drug delivery system.

In the crystal structure of γCDMOF, the macrocycles of γCD adopt the faces of a cube, with their primary faces pointing toward its interior ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). The γCDs are linked to one another by coordination of the alkali metal cations to the primary C-6--OH groups and the oxygen atoms of the glycoside ring. An approximately spherical pore (namely, chamber), with a diameter of 1.7 nm, resides at the center of the cube.^[@ref1]^ Invited molecules access the structures through 0.78 nm windows defined by the inner diameter of each dual γCD unit, forming infinite channels, which propagate along the tridimensional network.^[@ref4]^ This regular structure of dual γCD units plays a crucial role during the drug loading/release processes.^[@ref1]^ Moreover, docking experiments allowed detecting stronger interactions between the drug and the repeated dual γCD structure units in γCDMOF as compared to monomeric γCDs. In the light of important role of dual γCD structure units (D-γCD) in the structure, the molecular models of D-γCD and single γCD (S-γCD) were considered in present research.

This study focused on the loading of prednisolone (PNS) in γCDMOF, and the solvent of ethanol (EtOH) was selected, considering the fact that γCDMOF is unstable in water. Usually, the spherical^[@ref5]^ or cylindrical^[@ref6]^ models were used to predict the release characteristics, and the diffusion coefficient was often calculated according to the complex free-volume theory.^[@ref7]^ In this paper, a cubic model was used for the first time to predict the release characteristics, and the diffusion coefficient was derived from the molecular simulation results. At the same time, the distribution of the drug in the cubic body was determined. This study could provide a deep understanding of the drug loading/release mechanism and new ideas for designing CDMOF formulations.

2. Results and Discussion {#sec2}
=========================

The size of γCDMOF particles can be controlled from several micrometers to hundred micrometers. A batch of γCDMOF with a size of 150--250 μm was selected for experimental measurement and demonstrated the simulation. The loading efficiency of PNS to γCDMOF was about 1% (w/w), namely, 1:28 as the molar ratio between PNS and γCD, which is far less than a saturated status as a molar ratio of 1:2. Thus, the drug loading did not affect the study of the specific location of PNS in γCDMOF. In this paper, the crystalline characteristics and relevant properties were characterized. The XRD results in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"} showed that the crystal structure did not been destroyed during all the process.

![XRD results of pure γCDMOF and the drug-loaded complex PNS−γCDMOF.](ao9b01634_0013){#fig2}

2.1. FTIR Spectra {#sec2.1}
-----------------

The FTIR spectra of PNS, γCDMOF, and the drug-loaded complex (PNS−γCDMOF) had been obtained ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}) to provide more information for molecular modeling.

![FTIR spectra of free drug, empty γCDMOF, and drug-loaded γCDMOF. (a) PNS−γCDMOF. (b) γCDMOF. (c) PNS.](ao9b01634_0012){#fig3}

The stretch vibration band of ---C=O in PNS at 1654.5 cm^--1^ was detected in the γCDMOF, confirming the presence of the drug in the particles ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}). The symmetrical stretch vibration band of −CH~2~--/--CH-- in γCDMOF at 2854.9 cm^--1^ disappeared ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}). This is an indication that PNS molecules interacted with all the γCDs in the γCDMOF and not only with the surface of the crystals.^[@ref8]^ However, FTIR could not provide more insights into the drug-loaded crystal structures. Therefore, in an attempt to clarify the specific location of PNS molecules, molecular docking and molecular dynamics simulation methods were employed.

2.2. Docking Results {#sec2.2}
--------------------

The docking program was used to search for the most probable binding site in the periodic cavity (the hollow of γCD)/chamber (the hollow of γCDMOF) structures of the entire crystal. The docking results, based on the crystal structure characteristics of γCDMOF, showed that the PNS molecule preferred to stay in the hydrophobic cavity of the D-γCD channel of γCDMOF rather than in the large chamber of the γCDMOF ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}). According to this distribution pattern, the molar ratio of PNS and γCD could reach as high as 1:2 if all the cavities of the D-γCD structure were occupied. This conclusion was based on the crystal structure characteristics of γCDMOF not on the real drug-loading concentration.

![Ideal picture of PNS occupying the possible equivalent position of γCDMOF according to the docking result. Blue, PNS; other, γCDMOF.](ao9b01634_0003){#fig4}

The only possible way of drug penetration during loading or release was through the channels formed by the D-γCD structure. The cavity structure of D-γCD opposed a relatively higher resistance to the drug passage as compared to the chamber. Indeed, an obtained docking free energy of about −8.6 kcal·mol^--1^ indicated that the steric hindrance of loading/release was relatively larger, and the drugs were most likely to stay here. Therefore, there were two benefits to study the interaction dynamics here. First, the dynamic parameters could be obtained by the dynamic simulation for the speed limit position, and the global drug loading/release characteristics could be predicted. Second, more detailed information on specific interactions could be obtained. In view of the two benefits, the D-γCD and S-γCD configurations were extracted out of the global crystal structure to perform PMF calculation with PNS, and the two models were compared.

2.3. Potential of the Mean Force (PMF) Profile and Apparent *k*~off~ {#sec2.3}
--------------------------------------------------------------------

Due to the instability of γCDMOF in water, drug release studies were carried out in EtOH. To be consistent with this release process, the calculation of the PMF profile was based on the model of PNS and D-/S-γCD in EtOH solution ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}). The aim to study both S- and D-γCD models was to evaluate the difference of the γCDMOF model. This might also help us understand the nature of their interaction.

![MD models of PNS with (a) S-γCD and (b) D-γCD.](ao9b01634_0002){#fig5}

In this study, we used the same methods as our early work^[@ref9]^ to calculate the overall unbinding rate constant *k*~--r~ in the second stage and the apparent dissociation rate constant *k*~off~. Here, we only state the PMF profile of PNS with S- and D-γCD ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}) and provide the results of the *k*~--r~ and *k*~off~ ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}).

![Binding free energy profiles obtained from ABF calculation for the inclusion of PNS into (a) D-γCD and (b, c) S-γCD (two cases). The blue curves represent the binding free energy profile along the binding pathway, and the light blue segments represent the predictive error of the profile.](ao9b01634_0011){#fig6}

###### *k*~--r~ and *k*~off~ Data of PNS--D-γCD and PNS--S-γCD Systems

  system       *k*~--r~ (×10^4^ s^--1^)   *k*~off~ (×10^4^ s^--1^)
  ------------ -------------------------- --------------------------
  PNS--D-γCD   4.49 ± 3.96                4.49 ± 3.96
  PNS--S-γCD   (1.43 ± 1.13) × 10^7^       

Several conclusions can be drawn from the analysis of [Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}. First, the PMF profile and the calculated Δ*G* between PNS--S-γCD and PNS--D-γCD systems were quite different. In the S-γCD system, PNS easily accommodates without the need to penetrate through the narrow entrance, which has the largest resistance during binding/unbinding, as it is the case with the PNS--D-γCD system. Indeed, due to the symmetric characteristics of the D-γCD system, PNS has inevitably to go through the narrow entrance during loading and release, which leads to the absolute values of the docking free energy of the D-γCD system that were much higher than those of the S-γCD system.

From the calculated results, this gap was also quite obvious ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). The different structures between S- and D-γCD lead to the interaction mechanism, and the effect (*k*~--r~s of PNS--D-γCD and PNS--S-γCD systems were (4.49 ± 3.96) × 10^4^ s^--1^ and (1.43 ± 1.13) × 10^11^ s^--1^, respectively) was more different. As a result, the S-γCD was not fit for being directly used as the simplified model of γCDMOF. In the following, we mainly investigate the D-γCD model. In view that it was difficult to determine the binding/unbinding rate constant of the D-γCD structure in γCDMOF via experiment, it was more reliable to verify the calculation results by comparing the release behavior.

2.4. Drug Release Dynamics {#sec2.4}
--------------------------

The aim of this study was to model drug release by determining the variation of drug density (*d*) with time (*t*) in γCDMOF. The ability of γCDMOF to retain the drug within their porous structure was related to their crystal size (*l*) and *k*~off~, which was the diffusion limiting parameter. Considering the repetitive structure of the cubic γCDMOF crystals, the drug release process of γCDMOF could be regarded as an isotropic continuous diffusion process of a cube loaded with drugs. Thus, it was assumed that (i) the drug concentration outside the drug-loaded crystal was very low as in sink conditions and (ii) the γCDMOF particles were solid cubic crystals with an edge length of *l* and an initial drug density of unit 1. *D* is defined as the diffusion coefficient of drug in γCDMOF. Thus, the mathematical description of the system was ([eq [1](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"}):

This equation was defined in the region delimiting the 3D γCDMOF cube in the Cartesian coordinate. The analytical solution could not be resolved directly. Therefore, we used the numerical solution here. A particle size of *l* = 2 × 10^--3^ dm was used as the average crystal size. The diffusion coefficient *D* can be determined according to the following method:^[@ref10]^ Let the length of the unit cell of γCDMOF to be *a*. The difference of concentration between the two adjacent chamber was Δ*c*. The difference of total quantity was *a*^3^·Δ*c*. In view of the rate of drug passing D-γCD much slower than its diffusion rate in solvent (in the chamber), the D-γCD is the rate limiting unit. Therefore, the diffusion rate into the adjacent chamber was *a*^3^·Δ*c*·*k*~off~, and the average concentration gradient of two adjacent chambers was Δ*c*/*a*. According to the definition of the diffusion coefficient, the following equation ([eq [2](#eq2){ref-type="disp-formula"}](#eq2){ref-type="disp-formula"}) could be obtained:

Thus, *D* = *a*^2^·*k*~off~ was used as the diffusion coefficient where *a*^2^ = (31.006 × 10^--9^)^2^ dm^2^. To assign it (*t* = 15 min, 35 min, 1 h, and 3 h; *k* = 44941 × (31.006 × 10^--9^)^2^ L·mol^--1^·dm^2^), the concentration distribution of drug along the straight line, which passed through the body center and was perpendicular to one face, could be drawn in the following figure ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}).

![Relative density distribution of drug in the cubic crystal along the straight line, which passed through the body center and was perpendicular to one face at different times (*t*).](ao9b01634_0010){#fig7}

To show the distribution landscape of the drug in the cubic crystal more directly and intuitively, the distribution maps (*t* = 30 min) of drug concentration in the cubic crystal under the sink conditions are depicted in [Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}.

![Distribution map of drug density in the cubic crystal under the sink conditions at *t* = 30 min. (a) In the crystal body. (b) In the cross section, which passed through the body center and paralleled to one face. (c) In the cross section, which passed through the point of *l*/4 and paralleled to one face.](ao9b01634_0009){#fig8}

The predicted drug release profiles were obtained by integrating the drug density function (*d*) in the whole crystal and gathering the relative release content ([Figure [9](#fig9){ref-type="fig"}](#fig9){ref-type="fig"}). This profile was compared with the experimental data showing a good agreement (correlation coefficient = 99.92%). This supports our hypothesis, proving that the calculated positions and distribution during release of PNS in γCDMOF were accurate.

![Comparison of the theoretical release profile with experimental data.](ao9b01634_0008){#fig9}

The orange dispersed symbols depicted the experimental values (Exp.) and the error bars. The blue line depicted the calculated values (Cal.). The three independent experimental values at each time point have been divided by their respective *c*(∞), the drug concentration (*c*) when *t* = +∞. Since the drug was totally released after 12 h, the concentrations around *t* = 12 h were used as surrogate to *c*(∞).

2.5. Analysis of the Hydrogen Bond (Hbond) and van der Waals (VDW) Force {#sec2.5}
------------------------------------------------------------------------

Based on the above comparison of experimental and predicted data, the reliability of the calculation results and mathematical modeling were confirmed. Therefore, the model has been further used to explore more in detail the interaction between PNS and γCDMOF. The MD results showed that Hbond played an important role in the whole adsorption/release processes and provided a relatively large contribution to the free energy of the system. Either PNS interacted with S- or D-γCD systems, VDW force only played a supporting role. The solvent was EtOH with a relative weak polarity; thus, there was little tendency for PNS to enter into the hydrophobic cavity of γCD. Therefore, there were few hydrophobic interactions between PNS molecules and the hydrophobic CD cavities. However, some polar groups in the system played a relatively important role ([Figure [10](#fig10){ref-type="fig"}](#fig10){ref-type="fig"}).

![Interaction energy of PNS with D-γCD.](ao9b01634_0007){#fig10}

2.6. Mutual Confirmation of the Structure {#sec2.6}
-----------------------------------------

The conformation of PNS and γCDMOF in the minimum energy state was determined. [Figure [11](#fig11){ref-type="fig"}](#fig11){ref-type="fig"}a shows the conformation after energy minimization. [Figure [11](#fig11){ref-type="fig"}](#fig11){ref-type="fig"}b shows the docking result after energy minimization. It could be seen from [Figure [11](#fig11){ref-type="fig"}](#fig11){ref-type="fig"} that the two conformations were almost the same. This result was another confirmation of the validity of the method used for the calculation of free energy.

![Comparison of the docking result and MD result (the conformation with the minimum free energy). (a) MD result. (b) Docking result.](ao9b01634_0006){#fig11}

3. Conclusions {#sec3}
==============

In this study, the apparent dissociation constant, *k*~off~, of the model drug PNS from γCDMOF was predicted by molecular simulation. The approximate location of the drug in γCDMOF was identified using FTIR and molecular docking. In addition, a mathematical model was established to predict the drug release profile based on *k*~off~, which was in good agreement with the experimental measurement. It was concluded that the *k*~off~ of PNS from the dual γCD as the molecular structure unit of MOF was the primary parameter to control both the PNS distribution within γCDMOF particles and the drug release profiles from γCDMOF. The methodology developed here provided a reference for further investigation of the drug release mechanism in supramolecular systems as well as other complex crystalline drug delivery systems.

4. Methods and Materials {#sec4}
========================

4.1. Calculation Method {#sec4.1}
-----------------------

### 4.1.1. Molecular Models {#sec4.1.1}

The crystal structure of γCDMOF was extracted from the single-crystal structure of MOF-1 in the literature.^[@ref1]^ The receptor of docking used the crystal cell unit by deleting the K^+^ and OH^--^ ions. The S-/D-γCD structures were extracted from the crystal structure of γCDMOF. The molecular structure of PNS was extracted from the single-crystal structure of PNS obtained from the Cambridge Structural Database (Refcode: JIWPEL). The molecular models of PNS, S-γCD, and D-γCD are depicted in [Figure [12](#fig12){ref-type="fig"}](#fig12){ref-type="fig"}. Then, an energy optimization in vacuum employing the Amber 12 program was performed. During the molecular dynamics (MD) simulations, the glycosidic oxygen atoms of γCD were coerced to their initial position using a soft harmonic restraint to ensure the axis of *γ*CD parallel to the *z* axis. Because γCD has a rather rigid skeleton in γCDMOF, it can be regarded as a rigid body,^[@ref11]−[@ref13]^ and thus, harmonic restraints should not significantly affect the flexibility of γCD. For hydration of the model, an EtOH box confined by a period boundary condition was added to the simulation system. The initial size of the EtOH box was about 52 × 53 × 102 Å^3^ in all the systems studied.

![Molecular models of the 3D structure of (a) PNS, (b) D-γCD, and (c) S-γCD. Gray, carbon; red, oxygen. Hydrogen atoms were deleted.](ao9b01634_0001){#fig12}

### 4.1.2. Molecular Docking {#sec4.1.2}

The AutoDock Vina 1.1.2^[@ref14]^ was used to obtain the rough position of PNS in γCDMOF. Then, the docking result with the relatively low energy was performed the energy optimization with γCDMOF fixed. A Lamarckian genetic algorithm (LGA) in combination with a grid-based energy evaluation method were used for precalculating grid maps according to the interatomic potentials of all atom types present in the host and guest molecules, including the Lennard-Jones potentials for van der Waals interactions and Coulomb potentials for electrostatic interactions. A grid map of dimensions 70 Å × 70 Å × 70 Å, with a grid spacing of 0.375 Å, was employed to cover the γCDMOF structure. With the help of AutoDockTools,^[@ref15]^ the atomic partial charges were calculated by the Gasteiger--Marsili method.^[@ref16]^ The parameters used for the global search were an initial population of 50 individuals, a maximal number of energy evaluations of 1,500,000, and a maximal number of generations of 50,000 as an end criterion, and other docking parameters were set as default.

### 4.1.3. Molecular Dynamics Simulations {#sec4.1.3}

All the MD simulations were performed using the parallel package of NAMD 2.6 with the general amber force field (gaff).^[@ref17]^ The AmberTools in Amber 12 was used to prepare the Amber starting stuffs. The Gaussian 09 package was used to calculate partial atomic charges of PNS and EtOH molecules for the force field. The force field of γCD was extracted from the glycam force field website^[@ref18]^ in which the partial script was modified. The EtOH model was built manually as the solution model.^[@ref19]^ The particle mesh Ewald (PME) method was used for the treatment of long range electrostatic interactions. The nonbonded cutoff was set to 15.0 Å. A time step of 2.0 fs was used to integrate the equations of motion. The temperature was maintained at 310 K, employing Langevin dynamics with a damping coefficient of 1 ps^--1^. The Nosé--Hoover Langevin piston was used to control the pressure at 1 atm, with a piston period of 100 fs, a damping time constant of 50 fs, and a piston temperature of 310 K.

### 4.1.4. Free Energy Calculations {#sec4.1.4}

In the molecular systems, the heavy atoms of *γ*CD form the first subset of atoms. All the atoms of PNS formed the second subset of atoms separately. The pull originations were all along the *z* axis. The free energy profiles along an appropriate ordering parameter, ξ, describing receptor-ligand binding were generated using the adaptive biasing force (ABF) method. Next, the free energy was determined by integrating the average force acting along ξ, obtained from unconstrained MD simulations.^[@ref20]−[@ref23]^ To keep the central cavity of *γ*CD centered about the *z* axis during the MD simulations, the glycosidic oxygen atoms were restrained by means of weak harmonic restraints with a force constant of 1.0 kcal·mol^--1^·Å^--2^. Prior to each ABF run, the compound and their EtOH medium were equilibrated over a period of 20 ns. The reaction pathway was broken down into some consecutive windows with 2 Å wide. Over 20 ns of sampling was generated in each window. Instantaneous values of the force were accrued in bins 0.1 Å wide. One thousand samples were accumulated in each bin prior to application of the adaptive bias. The average force was interpolated over eight adjacent bins and progressively applied along ξ by means of a linear ramp. To improve uniformity of the sampling along ξ and continuity of the average force across adjacent windows, the width of the windows was adapted wherever needed. The standard error of the free energy difference was estimated using three parallel samples.

4.2. Experimental Method {#sec4.2}
------------------------

### 4.2.1. Materials {#sec4.2.1}

PNS (50-24-8, Dalian Meilun Biotech Co., Ltd.) and *γ*CD (17465-86-0, Maxdragon Biochem Ltd.) were of pharmaceutical grade. Potassium hydroxide (KOH, 85.0%, analytical reagent grade), methanol (MeOH, 99.5%, analytical reagent grade), EtOH (99.7%, analytical reagent grade), formic acid (high-performance liquid chromatography grade), and acetonitrile (high-performance liquid chromatography grade) were purchased from Sinopharm Chemical Reagent Co., Ltd. (Beijing, China). Pure water (18.4 MΩ cm) used in all experiments was obtained using a Milli-Q system (Millipore, Milford, MA, USA).

The γCDMOF particles were synthesized as previously described using a vapor diffusion method.^[@ref4],[@ref24]^ Briefly, γCD (162 mg, 0.125 mmol) and KOH (56 mg, 1 mmol) were dissolved in 5 mL of water followed by MeOH vapor diffusion at ambient temperature over 40 h. The produced γCDMOF with a size of 150--250 μm were selected as our drug loading vehicles.

### 4.2.2. FTIR Analysis {#sec4.2.2}

Fourier transform infrared spectroscopy (FTIR) of samples (*γ*CDMOF and PNS--*γ*CDMOF) were obtained using an FTIR spectrometer Thermo (Nicolet iS5, Thermo Scientific, USA). Briefly, the sample and potassium bromide were thoroughly mixed with a mass ratio of 1:10 and then compressed into a disk. Scans were obtained in the region of 400--4000 cm^--1^ at a resolution of 4 cm^--1^.

### 4.2.3. Drug Loading Experiments {#sec4.2.3}

The drug was loaded in γCDMOF by impregnation. For this, PNS was soaked in previously dried γCDMOF powder (50.0 mg) suspended into 10.0 mL of EtOH containing the drug (5.0 mg·mL^--1^). The suspension was incubated at 300 K under gentle stirring (150 rpm). The drug-loaded γCDMOF samples were collected by removing the EtOH solution when the drug concentration in supernatant was constant.

### 4.2.4. Drug Release Experiments {#sec4.2.4}

Drug release was performed using the paddle method by means of a dissolution apparatus (ZRS-8G, Tianjin Halylda Tech Co., Ltd.). About 15 mg of drug-loaded samples were added to the dissolution media containing 100 mL of EtOH at a temperature of 310 ± 0.2 K (*n* = 3). The solutions were stirred at a speed of 150 rpm. Aliquots of samples (0.5 mL) were withdrawn from each vessel at predetermined time points (18, 35, 60, 180, 360, and 720 min) and filtered over a cellulose acetate filter of 0.22 μm. At each time point, the same volume of fresh medium maintained at the same temperature was added to dissolution media. Samples withdrawn from the dissolution medium were analyzed for drug content by HPLC. All experiments were carried out in triplicate.

### 4.2.5. Concentration Determination by HPLC {#sec4.2.5}

The PNS concentration in the release media was determined by HPLC using a C18 column (4.6 mm × 150 mm, 3.6 μm i.d., Agilent Co., Ltd) at the flow rate of 0.6 mL·min^--1^ at 298 K. Eluent A was 0.1% formic acid, and eluent B was acetonitrile. The gradient started with 10% B increasing to 90% within 10 min and maintained for 3 min, and then the eluent B decreased to 10% in 1 min and then kept unchanged for 6 min. The injection volume and detection wavelength were 50 μL and 240 nm, respectively.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.9b01634](http://pubs.acs.org/doi/abs/10.1021/acsomega.9b01634).Method of scanning electron microscope, method of nitrogen adsorption--desorption isotherm, method of X-ray powder diffraction, morphology analysis, and gas adsorption performance of γ-CDMOF ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01634/suppl_file/ao9b01634_si_001.pdf))
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